A Multiplex Test Assessing
biomarkers
bladder cancer
methylation
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
24 Feb 2020
24 Feb 2020
Historique:
received:
28
01
2020
revised:
14
02
2020
accepted:
18
02
2020
entrez:
28
2
2020
pubmed:
28
2
2020
medline:
28
2
2020
Statut:
epublish
Résumé
Bladder cancer (BlCa) is a common malignancy with significant morbidity and mortality. Current diagnostic methods are invasive and costly, showing the need for newer biomarkers. Although several epigenetic-based biomarkers have been proposed, their ability to discriminate BlCa from common benign conditions of the urinary tract, especially inflammatory diseases, has not been adequately explored. Herein, we sought to determine whether VIM
Identifiants
pubmed: 32102337
pii: jcm9020605
doi: 10.3390/jcm9020605
pmc: PMC7073678
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto Português de Oncologia do Porto
ID : CI-IPOP-27-2016
Organisme : Fundação para a Ciência e a Tecnologia
ID : SFRH/BD/112673/2015
Références
Cancer Res. 2003 May 1;63(9):2306-11
pubmed: 12727854
Epigenomics. 2015;7(6):1003-15
pubmed: 26479312
BMC Cancer. 2017 Apr 7;17(1):247
pubmed: 28388880
BMC Cancer. 2016 Sep 01;16:704
pubmed: 27586786
Int J Mol Sci. 2019 May 30;20(11):
pubmed: 31151158
N Engl J Med. 2008 Mar 13;358(11):1148-59
pubmed: 18337604
Br J Cancer. 2017 Feb 28;116(5):634-639
pubmed: 28081549
Ther Adv Urol. 2011 Feb;3(1):19-33
pubmed: 21789096
Tumour Biol. 2016 Jun;37(6):7633-44
pubmed: 26687649
Pathol Res Pract. 2019 Jun;215(6):152411
pubmed: 30987831
Eur Urol. 2017 Mar;71(3):462-475
pubmed: 27375033
Biomed Pharmacother. 2016 Jul;81:431-438
pubmed: 27261623
Eur Urol. 2019 Nov;76(5):639-657
pubmed: 31443960
Cancer Treat Rev. 2018 Sep;69:39-52
pubmed: 29902678
AJR Am J Roentgenol. 2014 Jun;202(6):1179-86
pubmed: 24848814
Cancer Lett. 2014 Jan 28;342(2):264-74
pubmed: 22198482
Cell Mol Life Sci. 2011 Sep;68(18):3033-46
pubmed: 21637948
DNA Cell Biol. 2013 Jul;32(7):386-92
pubmed: 23682613
Clin Cancer Res. 2010 Dec 1;16(23):5842-51
pubmed: 20975101
BMC Cancer. 2013 Jun 04;13:275
pubmed: 23735005
Cells Tissues Organs. 2007;185(1-3):191-203
pubmed: 17587825
BMC Cancer. 2018 Nov 28;18(1):1179
pubmed: 30486878
J Gen Intern Med. 2002 Aug;17(8):646-9
pubmed: 12213147
Eur Urol. 2017 Jan;71(1):96-108
pubmed: 27370177
Eur Urol. 2016 Dec;70(6):916-919
pubmed: 27417036
J Cancer Res Clin Oncol. 2009 Dec;135(12):1717-27
pubmed: 19565266
J Cell Physiol. 2014 Jul;229(7):834-44
pubmed: 24243035
Lancet. 2009 Jul 18;374(9685):239-49
pubmed: 19520422
Br J Cancer. 2008 Nov 4;99(9):1476-83
pubmed: 18854838
Clin Cancer Res. 2007 Dec 15;13(24):7296-304
pubmed: 18094410
Clin Cancer Res. 2002 Feb;8(2):464-70
pubmed: 11839665
Eur Urol. 2016 Mar;69(3):438-47
pubmed: 26508308
Clin Cancer Res. 2015 Sep 1;21(17):4004-13
pubmed: 26023083
BMC Cancer. 2016 May 16;16:315
pubmed: 27184257
Methods Mol Biol. 2017;1546:311-315
pubmed: 27896781
Nat Rev Dis Primers. 2017 Apr 13;3:17022
pubmed: 28406148
Eur Urol. 2010 Jul;58(1):96-104
pubmed: 19674832
Oncotarget. 2016 Jan 19;7(3):2754-64
pubmed: 26700620
Eur Urol. 2016 Jul;70(1):106-119
pubmed: 26996659
Am J Clin Pathol. 2009 Nov;132(5):785-93
pubmed: 19846822